» Articles » PMID: 32724069

Ryk Modulates the Niche Activity of Mesenchymal Stromal Cells by Fine-tuning Canonical Wnt Signaling

Overview
Journal Exp Mol Med
Date 2020 Jul 30
PMID 32724069
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The importance of modulating the intensity of Wnt signaling has been highlighted in various biological models, but their mechanisms remain unclear. In this study, we found that Ryk-an atypical Wnt receptor with a pseudokinase domain-has a Wnt-modulating effect in bone marrow stromal cells to control hematopoiesis-supporting activities. We first found that Ryk is predominantly expressed in the mesenchymal stromal cells (MSCs) of the bone marrow (BM) compared with hematopoietic cells. Downregulation of Ryk in MSCs decreased their clonogenic activity and ability to support self-renewing expansion of primitive hematopoietic progenitors (HPCs) in response to canonical Wnt ligands. In contrast, under high concentrations of Wnt, Ryk exerted suppressive effects on the transactivation of target genes and HPC-supporting effects in MSCs, thus fine-tuning the signaling intensity of Wnt in BM stromal cells. This ability of Ryk to modulate the HPC-supporting niche activity of MSCs was abrogated by induction of deletion mutants of Ryk lacking the intracellular domain or extracellular domain, indicating that the pseudokinase-containing intracellular domain mediates the Wnt-modulating effects in response to extracellular Wnt ligands. These findings indicate that the ability of the BM microenvironment to respond to extracellular signals and support hematopoiesis may be fine-tuned by Ryk via modulation of Wnt signaling intensity to coordinate hematopoietic activity.

Citing Articles

The dynamic interaction of pediatric ALL cells and MSCs: influencing leukemic cell survival and modulating MSC β-catenin expression.

Ozdemir-Sanci T, Piskin I, Koksal Y, Cayli S, Ozbek N, Ozguner H Histochem Cell Biol. 2025; 163(1):26.

PMID: 39836255 PMC: 11750926. DOI: 10.1007/s00418-025-02353-w.


Therapeutic advances of targeting receptor tyrosine kinases in cancer.

Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A Signal Transduct Target Ther. 2024; 9(1):201.

PMID: 39138146 PMC: 11323831. DOI: 10.1038/s41392-024-01899-w.


A Multifunctional Therapeutic Strategy Using P7C3 as A Countermeasure Against Bone Loss and Fragility in An Ovariectomized Rat Model of Postmenopausal Osteoporosis.

Wei F, Hughes M, Omer M, Ngo C, Pugazhendhi A, Kolanthai E Adv Sci (Weinh). 2024; 11(21):e2308698.

PMID: 38477537 PMC: 11151083. DOI: 10.1002/advs.202308698.


Signaling Pathways in Trans-differentiation of Mesenchymal Stem Cells: Recent Advances.

Kaviarasan V, Deka D, Balaji D, Pathak S, Banerjee A Methods Mol Biol. 2023; 2736:207-223.

PMID: 37140811 DOI: 10.1007/7651_2023_478.


The Role of Notch and Wnt Signaling in MSC Communication in Normal and Leukemic Bone Marrow Niche.

Takam Kamga P, Bazzoni R, Dal Collo G, Cassaro A, Tanasi I, Russignan A Front Cell Dev Biol. 2021; 8:599276.

PMID: 33490067 PMC: 7820188. DOI: 10.3389/fcell.2020.599276.

References
1.
Mendelson A, Frenette P . Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat Med. 2014; 20(8):833-46. PMC: 4459580. DOI: 10.1038/nm.3647. View

2.
Morrison S, Scadden D . The bone marrow niche for haematopoietic stem cells. Nature. 2014; 505(7483):327-34. PMC: 4514480. DOI: 10.1038/nature12984. View

3.
Oh I, Humphries R . Concise review: Multidimensional regulation of the hematopoietic stem cell state. Stem Cells. 2011; 30(1):82-8. DOI: 10.1002/stem.776. View

4.
Oh I, Kwon K . Concise review: multiple niches for hematopoietic stem cell regulations. Stem Cells. 2010; 28(7):1243-9. DOI: 10.1002/stem.453. View

5.
Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View